Glioma progression and microglial activation are induced by tumor-derived macrophage colony-stimulating factor (M-CSF, CSF1) and granulocyte-macrophage colony-stimulating factor (GM-CSF, CSF2) [174]. Here, CSF2 is linked to central nervous system cancer.